APPLICATIONS PUBLISHED 21 NOVEMBER 2004
Published: 2-Jun-2005
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
System for transvaginal drug delivery
Hi-Glenic Intra-Vaginal Technology; Yissum Research Development Company of the Hebrew University of Jerusalem 1478337*
Powder inhalation containing CGRP-antagonist BIBN4096 and method for the production thereof
Boehringer Ingelheim Pharmaceuticals 1478338*
Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes for making and using the same
Schering 1478339*
Pharmaceutical formulation comprising an aqueous suspension of a n androstane derivative for the treatment of inflammatory and allergic conditions
Glaxo Group 1478340*
Efficient nucleic acid encapsulation into medium sized liposomes
Elan Pharmaceutical 1478341*
Sterile filtered nanoparticle formulations of budesonide and beclomethasone having tyloxapol as a surface stabiliser
Elan Pharmaceutical International 1478342*
Compsns and methods for delivery of poorly water soluble drugs and methods of treatment
Crititech 1478343*
Melt extrusion consisting of salts of active ingredients
Roehm 1478344*
Novel pharmaceutical dosage form and methods for producing same
SmithKline Beecham 1478345*
Fast disintegrating tablets
Phoqus Pharmaceuticals 1478346*
Dry granulated formulations of azithromycin
Pfizer Products 1478347*
Microinfusion device
The Cleveland Clinic Foundation 1478348*
A method for releasing nanosized particles of an active substance from a diffusion-controlled pharmaceutical compsn for oral use
Amarin Development 1478349*
Pharmaceutical dosage forms comprising tablet core having a tensile strength below 38N/sq cm and a coating to protect the soft cores
Phoqus Pharmaceuticals 1478350*
Rapidly soluble film covering based on polyvinylalcohol-polyether graft copolymers combined with components containing hydroxyl, amide or ester functions
BASF 1478351*
Pharmaceutical dosage form and method for the production thereof
Roehm 1478352*
Sustained release pharmaceutical compsn
Smart Drug Systems 1478353*
Use of TGF-beta antagonists to treat or to prevent chronic transplant rejection
Genzyme 1478354*
Antitumour compsns containing taxane derivatives
Aventis Pharma 1478355*
Therapeutic compounds
President and Fellows of Harvard University 1478356*
Tricyclic pyrazole derivatives, process for their preparation and their use as antitumour agents
Pharmacia Italia 1478357*
Aryl ureas with angiogenesis inhibiting activity
Bayer Pharmaceuticals 1478358*
Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases
Celltech R&D 1478359*
Agents which interact with a serotonin transporter for the treatment of cancer
The University of Birmingham 1478360*
Arylsulphone derivatives
Pharmacia & Upjohn 1478361*
A combination treatment for acute myocardial infarction
Orion Corp 1478362*
Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
Abbott Laboratories 1478363*
Selective antibacterial agents
4SC AG 1478364*
Combination consisting of trapidil and serotonin antagonists such as cyproheptadine or pizotifen for inhibiting angiogenesis
Nowak, Goetz 1478365*
Pharmaceutical combinations of COX-2 inhibitors and opiates
Adcock Ingram 1478366*
Intraspinal continuous infusion of midazolam hydrochloride for the treatment of pain
Board of Regents The University of Texas System 1478367*
Use of benzothiazepines having activity as inhibitors of ileal acid transport for reducing cholesterololemia
AstraZeneca 1478368*
Use of biogenic estriol diester prodrugs for the treatment of autoimmune diseases
Schering 1478369*
Use of biogenic estriol sulphamate prodrugs for the treatment of autoimmune diseases
Schering 1478370*
Methods and products for enhancing immune responses using imidazoquinoline compounds
University of Iowa Research Foundation; Coley Pharmaceutical GmbH; Coley Pharmaceutical Group 1478371*
Long acting parasiticidal compsn containing a salicylanilide compound, a polymeric species and at least one other anti-parasitic compound
Norbrook Laboratories 1478372*
Pharmaceutical compsns comprising one or more sterpids one or more tetrahydrofolate components and vitamin B12
Schering 1478373*
Formulations comprising psychotropic drugs and selenium
Laxdale 1478374*
Compsns for the treatment of pilosebaceous gland inflammations comprising aluminium fluoride
R & Derm 1478375*
Immunostimulatory agent comprising a biomass of methanotrophic bacterium
Norferm 1478376*
A compsn
New Zealand Botanical Oils 1478377*
Anti-allergic complex molecules
Allergene 1478378*
Humanised lactoferrin and uses thereof
Campine 1478379*
Use of tyrosine kinase inhibitors for treating CNS disorders
AB Science 1478380*
Use of soluble gamma delta T cell receptors for regulating T cell function
National Jewish Medical and Research Centre 1478381*
Method for producing a powder inhalant containing a salt of the CGRP antagonist BIBN4096
Boehringer Ingelheim Pharma 1478382*
Compsns and methods for promoting myocardial and peripheral angiogenesis
Zimmer Orthobiologics 1478383*
Method for increasing the survival of dopamine secreting cells
Ludwig Institute for Cancer Research 1478384*
BMP inhibitors for the treatment of spondyloarthropathies
K. U. Leuven Research & Development 1478385*
Method of drying water-borne materials
Pasex Corp 1478386*
Pharmaceutical compsn and method for treatment or prevention of vascular disease or states of tissue hyperfusion with hypoxic and/or ischaemic consequences
Norrby, Klas 1478387*
